Advisor Group Holdings, Inc. United Therapeutics Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,436 shares of UTHR stock, worth $5.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,436

Previous 12,331 17.07%

Holding current value

$5.38 Million

Previous $3.93 Million 31.7%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $654,739 - $765,272	2,105 Added 17.07%	14,436 $5.17 Million
Q2 2024 Aug 13, 2024	SELL	$228.26 - $319.04 $286,238 - $400,076	-1,254 Reduced 9.23%	12,331 $3.93 Million
Q1 2024 May 10, 2024	SELL	$210.76 - $249.51 $3.96 Million - $4.68 Million	-18,774 Reduced 58.02%	13,585 $3.12 Million
Q4 2023 Feb 12, 2024	SELL	$214.88 - $256.94 $411,495 - $492,040	-1,915 Reduced 5.59%	32,359 $7.12 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $5.1 Million - $5.97 Million	24,054 Added 235.36%	34,274 $7.74 Million
Q2 2023 Aug 21, 2023	SELL	$205.19 - $232.99 $992,093 - $1.13 Million	-4,835 Reduced 32.12%	10,220 $2.26 Million
Q2 2023 Aug 10, 2023	BUY	$205.19 - $232.99 $973,831 - $1.11 Million	4,746 Added 46.04%	15,055 $3.32 Million
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $916,495 - $1.19 Million	-4,303 Reduced 29.45%	10,309 $2.31 Million
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $1.83 Million - $2.49 Million	8,887 Added 155.23%	14,612 $4.06 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $94,127 - $113,050	463 Added 8.8%	5,725 $1.2 Million
Q2 2022 Aug 10, 2022	SELL	$174.81 - $241.14 $40,206 - $55,462	-230 Reduced 4.19%	5,262 $1.24 Million
Q1 2022 May 04, 2022	BUY	$166.16 - $213.96 $371,035 - $477,772	2,233 Added 68.52%	5,492 $1.3 Million
Q3 2021 Nov 05, 2021	BUY	$179.86 - $214.88 $37,410 - $44,695	208 Added 6.82%	3,259 $603,000
Q2 2021 Aug 02, 2021	BUY	$170.47 - $211.93 $27,445 - $34,120	161 Added 5.57%	3,051 $548,000
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $44,642 - $50,706	290 Added 11.15%	2,890 $487,000
Q4 2020 Feb 10, 2021	SELL	$101.87 - $151.79 $5,093 - $7,589	-50 Reduced 1.89%	2,600 $396,000
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $14,285 - $17,321	143 Added 5.7%	2,650 $274,000
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $128,723 - $174,638	1,388 Added 124.04%	2,507 $303,000
Q1 2020 May 18, 2020	BUY	$79.39 - $115.35 $88,837 - $129,076	1,119 New	1,119 $108,000

Others Institutions Holding UTHR

# of Institutions

669

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. United Therapeutics Corp Transaction History